| Today's News and Trends | The ongoing saga continues. Both Germany and Canada have now limited the use of the AstraZeneca vaccine among younger adults. The ongoing saga continues. Both Germany and Canada have now limited the use of the AstraZeneca vaccine among younger adults. | |
| The authors tracked outcomes from more than 386,000 patients treated from 2001 to 2018, sharing their findings in Hypertension. The authors tracked outcomes from more than 386,000 patients treated from 2001 to 2018, sharing their findings in Hypertension. | |
| The new AI tool can be used alongside GE Healthcare’s full line of Venue ultrasound systems, including the new Venue Fit. The new AI tool can be used alongside GE Healthcare’s full line of Venue ultrasound systems, including the new Venue Fit. | |
| “Value can be defined as delivered care divided by cost,” the specialists wrote. “Ideally, each patient receives the same good quality of care in an equitable, timely way.” “Value can be defined as delivered care divided by cost,” the specialists wrote. “Ideally, each patient receives the same good quality of care in an equitable, timely way.” | |
| | One important detail, however, was that acute kidney injury was more common for kidney transplant recipients. The researchers listed numerous potential explanations for this trend. One important detail, however, was that acute kidney injury was more common for kidney transplant recipients. The researchers listed numerous potential explanations for this trend. | |
| The analysis, published in the Journal of the American College of Cardiology, tracked nearly 1,000 patients treated for their first myocardial infarction from November 1995 to October 1997. The analysis, published in the Journal of the American College of Cardiology, tracked nearly 1,000 patients treated for their first myocardial infarction from November 1995 to October 1997. | |
| The solution’s approval was based on 30-day and six-month data from a clinical study focused on mortality and hemodynamic function. The solution’s approval was based on 30-day and six-month data from a clinical study focused on mortality and hemodynamic function. | |
| | Two healthcare heavyweights are combining forces to form a technology center they hope will, over the next 10 years, “fundamentally advance the pace” of discovery in medical science and healthcare innovation. Two healthcare heavyweights are combining forces to form a technology center they hope will, over the next 10 years, “fundamentally advance the pace” of discovery in medical science and healthcare innovation. | |
| |
|
| | |
|